AblaCare System for Polycystic Ovary Syndrome (ULTRA-US Trial)

"Yes, the information on clinicialtrials.gov attests that this research effort is presently enrolling participants. The investigation was initially posted in May 12th 2022 and had its last update 5 weeks later on July 5th 2022. Five individuals are required to be recruited from a single medical center."

"Indeed, clinicaltrials.gov reports that recruitment for this study is still underway. It was first posted on May 12th 2022 and updated most recently on July 5th 2022. At the moment, the team behind it needs to find 5 participants from a single medical site."

"This medical trial has set the age of eligibility at 18 to 40 years old. However, there are alternate trials for patients who do not meet this criteria; 401 studies catering to minors and 1019 for older people over 65."

"This medical trial is open to five sterile females between the ages of 18 and 40. For enrollment, individuals must fulfill a variety of prerequisites including: WHO 2010 parameters for sperm concentration (≥ 15 million/mL) and motility (≥ 40%), normal morphology (> 4%), ultrasonographic evidence or hyperandrogenaemia, ovarian volume ≥ 10ml, patency in at least one fallopian tube within three years prior to submission date, willingness to comply with study requirements as outlined by the Clinical Investigation Plan-specified follow-up evaluation, fluency in an IRB approved written language translation of the Patient Information and Informed"